NRTI Sparing Therapy in Virologically Controlled HIVNRTI Sparing Therapy in Virologically Controlled HIV

This study explores the combination of rilpivirine plus boosted darunavir as an option when switching from standard cART in patients who are virologically suppressed. JAIDS: Journal of Acquired Immune Deficiency Syndromes
Source: Medscape Hiv-Aids Headlines - Category: Infectious Diseases Tags: HIV/AIDS Journal Article Source Type: news